These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 27412917)

  • 21. The mutant p53-ID4 complex controls VEGFA isoforms by recruiting lncRNA MALAT1.
    Pruszko M; Milano E; Forcato M; Donzelli S; Ganci F; Di Agostino S; De Panfilis S; Fazi F; Bates DO; Bicciato S; Zylicz M; Zylicz A; Blandino G; Fontemaggi G
    EMBO Rep; 2017 Aug; 18(8):1331-1351. PubMed ID: 28652379
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibitor of differentiation 4 (ID4) acts as an inhibitor of ID-1, -2 and -3 and promotes basic helix loop helix (bHLH) E47 DNA binding and transcriptional activity.
    Sharma P; Chinaranagari S; Chaudhary J
    Biochimie; 2015 May; 112():139-50. PubMed ID: 25778840
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibitor of differentiation 4 (ID4): From development to cancer.
    Patel D; Morton DJ; Carey J; Havrda MC; Chaudhary J
    Biochim Biophys Acta; 2015 Jan; 1855(1):92-103. PubMed ID: 25512197
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Direct interaction between BRCA1 and the estrogen receptor regulates vascular endothelial growth factor (VEGF) transcription and secretion in breast cancer cells.
    Kawai H; Li H; Chun P; Avraham S; Avraham HK
    Oncogene; 2002 Oct; 21(50):7730-9. PubMed ID: 12400015
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Annexin A8 is up-regulated during mouse mammary gland involution and predicts poor survival in breast cancer.
    Stein T; Price KN; Morris JS; Heath VJ; Ferrier RK; Bell AK; Pringle MA; Villadsen R; Petersen OW; Sauter G; Bryson G; Mallon EA; Gusterson BA
    Clin Cancer Res; 2005 Oct; 11(19 Pt 1):6872-9. PubMed ID: 16203777
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Insights into the targeted elimination of BRCA1-defective cancer stem cells.
    Somasundaram V; Srinivas P
    Med Res Rev; 2012 Sep; 32(5):948-67. PubMed ID: 20814958
    [TBL] [Abstract][Full Text] [Related]  

  • 27. RANK ligand as a potential target for breast cancer prevention in BRCA1-mutation carriers.
    Nolan E; Vaillant F; Branstetter D; Pal B; Giner G; Whitehead L; Lok SW; Mann GB; ; Rohrbach K; Huang LY; Soriano R; Smyth GK; Dougall WC; Visvader JE; Lindeman GJ
    Nat Med; 2016 Aug; 22(8):933-9. PubMed ID: 27322743
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Molecular insights on basal-like breast cancer.
    Valentin MD; da Silva SD; Privat M; Alaoui-Jamali M; Bignon YJ
    Breast Cancer Res Treat; 2012 Jul; 134(1):21-30. PubMed ID: 22234518
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Aberrant hypermethylation of ID4 gene promoter region increases risk of lymph node metastasis in T1 breast cancer.
    Umetani N; Mori T; Koyanagi K; Shinozaki M; Kim J; Giuliano AE; Hoon DS
    Oncogene; 2005 Jul; 24(29):4721-7. PubMed ID: 15897910
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of Id4 as a regulator of BRCA1 expression by using a ribozyme-library-based inverse genomics approach.
    Beger C; Pierce LN; Kruger M; Marcusson EG; Robbins JM; Welcsh P; Welch PJ; Welte K; King MC; Barber JR; Wong-Staal F
    Proc Natl Acad Sci U S A; 2001 Jan; 98(1):130-5. PubMed ID: 11136250
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Promotion of BRCA1-associated triple-negative breast cancer by ovarian hormones.
    Lee EY
    Curr Opin Obstet Gynecol; 2008 Feb; 20(1):68-73. PubMed ID: 18197009
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Analysis of Brca1-deficient mouse mammary glands reveals reciprocal regulation of Brca1 and c-kit.
    Smart CE; Wronski A; French JD; Edwards SL; Asselin-Labat ML; Waddell N; Peters K; Brewster BL; Brooks K; Simpson K; Manning N; Lakhani SR; Grimmond S; Lindeman GJ; Visvader JE; Brown MA
    Oncogene; 2011 Mar; 30(13):1597-607. PubMed ID: 21132007
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Germline mutation of Brca1 alters the fate of mammary luminal cells and causes luminal-to-basal mammary tumor transformation.
    Bai F; Smith MD; Chan HL; Pei XH
    Oncogene; 2013 May; 32(22):2715-25. PubMed ID: 22777348
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reduction of BRCA1 protein expression in Japanese sporadic breast carcinomas and its frequent loss in BRCA1-associated cases.
    Yoshikawa K; Honda K; Inamoto T; Shinohara H; Yamauchi A; Suga K; Okuyama T; Shimada T; Kodama H; Noguchi S; Gazdar AF; Yamaoka Y; Takahashi R
    Clin Cancer Res; 1999 Jun; 5(6):1249-61. PubMed ID: 10389907
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression of growth factors and oncogenes in normal and tumor-derived human mammary epithelial cells.
    Zajchowski D; Band V; Pauzie N; Tager A; Stampfer M; Sager R
    Cancer Res; 1988 Dec; 48(24 Pt 1):7041-7. PubMed ID: 3191480
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Met signaling regulates growth, repopulating potential and basal cell-fate commitment of mammary luminal progenitors: implications for basal-like breast cancer.
    Gastaldi S; Sassi F; Accornero P; Torti D; Galimi F; Migliardi G; Molyneux G; Perera T; Comoglio PM; Boccaccio C; Smalley MJ; Bertotti A; Trusolino L
    Oncogene; 2013 Mar; 32(11):1428-40. PubMed ID: 22562252
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Basal-like subtype and BRCA1 dysfunction in breast cancers.
    Miyoshi Y; Murase K; Oh K
    Int J Clin Oncol; 2008 Oct; 13(5):395-400. PubMed ID: 18946749
    [TBL] [Abstract][Full Text] [Related]  

  • 38. ID4: a new player in the cancer arena.
    Dell'Orso S; Ganci F; Strano S; Blandino G; Fontemaggi G
    Oncotarget; 2010 May; 1(1):48-58. PubMed ID: 21293053
    [TBL] [Abstract][Full Text] [Related]  

  • 39. BRCA1-IRIS activates cyclin D1 expression in breast cancer cells by downregulating the JNK phosphatase DUSP3/VHR.
    Hao L; ElShamy WM
    Int J Cancer; 2007 Jul; 121(1):39-46. PubMed ID: 17278098
    [TBL] [Abstract][Full Text] [Related]  

  • 40. BRCA1 controls the cell division axis and governs ploidy and phenotype in human mammary cells.
    He Z; Kannan N; Nemirovsky O; Chen H; Connell M; Taylor B; Jiang J; Pilarski LM; Fleisch MC; Niederacher D; Pujana MA; Eaves CJ; Maxwell CA
    Oncotarget; 2017 May; 8(20):32461-32475. PubMed ID: 28427147
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.